在BI-RADS评估中加入无模型扩散MRI标志物可提高乳腺病变诊断特异性
单机构回顾性研究纳入99例女性(69个恶性、38个良性病灶),在3-T MRI上采用b值0、200、1500 sec/mm²的扩散加权成像计算组织特征指数(S-index)与移位ADC。S-index联合BI-RADS的AUC达0.98,高于单独BI-RADS的0.91(P < .001),敏感度94%、特异度95%。
要点
- S-index联合BI-RADS的AUC为0.98,高于单独BI-RADS的0.91(P < .001)。
- 联合方案的敏感度为65/69(94%),特异度为36/38(95%)。
- S-index与移位ADC的AUC均为0.95,略高于BI-RADS的0.91(P = .22)。
核心结论
- S-index有潜力高准确度分类乳腺病变类型,尤其与动态对比增强MRI联合时,并与浸润性乳腺癌的组织学预后因素相关。
研究设计与样本
- 单机构回顾性研究,2017年4月至2018年9月行乳腺MRI的患者,共99例女性(平均年龄54岁±14),69个恶性、38个良性病灶,采用3-T MRI系统行DCE-MRI和DW成像,DW成像b值为0、200、1500 sec/mm²。
关键影像表现/征象
- 恶性病灶S-index均值75.9±17.4,高于良性病灶均值31.6±21.0(P < .001)。
诊断标准与关键数值
- S-index与移位ADC总体诊断效能相同,AUC均为0.95(95%CI:0.91,0.99),略高于BI-RADS的AUC 0.91(95%CI:0.87,0.96;P = .22)。
- S-index联合BI-RADS的AUC为0.98(95%CI:0.96,1.00),高于单独BI-RADS(P < .001),敏感度65/69(94%;95%CI:85%,98%),特异度36/38(95%;95%CI:81%,99%)。
- S-index在孕激素受体和人表皮生长因子受体2状态间差异有统计学意义(P = .003和P < .001)。
临床应用与阅片要点
- 作者认为S-index有潜力用于乳腺病变分类,尤其与动态对比增强MRI联合时。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The apparent diffusion coefficient (ADC) is a commonly used quantitative diffusion-weighted (DW) imaging marker in breast lesion assessment; however, reported ADC values to distinguish malignant and benign lesions show wide variability. Purpose To investigate the diagnostic performance of a tissue signature index (S-index) as a model-free diffusion marker to differentiate malignant and benign breast lesions. Materials and Methods This was a single-institution retrospective study of patients who underwent breast MRI from April 2017 to September 2018. Dynamic contrast-enhanced (DCE) MRI and DW imaging were performed with a 3-T MRI system. For DW imaging, three b values (0, 200, and 1500 sec/mm2) were used for Breast Imaging Reporting and Data Systems (BI-RADS) scoring and to calculate the S-index and a shifted ADC. The diagnostic performances of S-index, shifted ADC, and BI-RADS scoring were evaluated by using receiver operating coefficient analysis. Results The study involved 99 women (mean age, 54 years ± 14 [standard deviation]) with 69 malignant and 38 benign lesions. The S-index was higher for malignant lesions (mean, 75.9 ± 17.4) than for benign lesions (mean, 31.6 ± 21.0; P < .001). Overall diagnostic performance was identical for S-index and shifted ADC (area under the receiver operating characteristic curve [AUC], 0.95; 95% confidence interval [CI]: 0.91, 0.99) and slightly higher than for BI-RADS (AUC, 0.91; 95% CI: 0.87, 0.96; P = .22). The AUC of S-index combined with BI-RADS reached 0.98 (95% CI: 0.96, 1.00), higher than for BI-RADS alone (P < .001), yielding high sensitivity (65 of 69 [94%]; 95% CI: 85%, 98%) and specificity (36 of 38 [95%]; 95% CI: 81%, 99%). Significant differences were identified with the S-index for progesterone receptor and human epidermal growth factor receptor type 2 status (P = .003 and P < .001, respectively). Conclusion The signature index has the potential to enable classification of breast lesion types with high accuracy, especially in combination with dynamic contrast-enhanced MRI and correlates with histologic prognostic factors in invasive breast cancer. © RSNA, 2019 Online supplemental material is available for this article.
引用
- Goto M, Le Bihan D, Yoshida M, et al. Adding a Model-free Diffusion MRI Marker to BI-RADS Assessment Improves Specificity for Diagnosing Breast Lesions. Radiology. 2019. PMID: 31112086. doi:10.1148/radiol.2019181780
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。